Travere Therapeutics, Inc. (TVTX): hiring and filings, side by side
Two independent records on the same company. What Travere Therapeutics, Inc. tells a regulator, and what it is doing on its own careers page. Neither is a comment on the other, which is exactly why they are worth reading together.
Why this page is not somewhere else. Trading-signal vendors sell the filings and workforce-data vendors sell the hiring, but the two are rarely joined on the same company in the same window. The hiring side here is read from the employer's own applicant tracking system rather than scraped from a job board, every filing links back to the document on SEC EDGAR, and each score states the inputs it was built from so you can recompute it instead of trusting it.
What it is hiring right now
| Open roles | 51 |
| Departments | 0 |
| Countries | 2 |
| Flagged remote by the employer | 8 |
| Roles first seen in the last 14 days | 11 |
| Roles we have seen close | 43 |
Where the roles are: United States (39), Switzerland (1).
What it filed
2026-09-21 - Material corporate event (8-K) - score 70/100
items: Departure/appointment of directors or officers; Financial statements and exhibits
2026-09-17 - Planned insider sale (Form 144) - score 67/100
value: $525,741 · approx sale date: 2026-09-17 · role: Officer · seller: PETER HEERMA
2026-09-17 - Planned insider sale (Form 144) - score 87/100
value: $6,887,136 · approx sale date: 2026-09-17 · role: Director · seller: ERIC DUBE
2026-09-16 - Planned insider sale (Form 144) - score 87/100
value: $7,054,254 · approx sale date: 2026-09-16 · role: Officer · seller: WILLIAM ROTE
2026-09-16 - Planned insider sale (Form 144) - score 100/100
value: $10,796,540 · approx sale date: 2026-09-16 · role: Officer · seller: PETER HEERMA
2026-09-16 - Planned insider sale (Form 144) - score 100/100
value: $12,242,021 · approx sale date: 2026-09-16 · role: Director · seller: ERIC DUBE
2026-09-15 - Planned insider sale (Form 144) - score 67/100
value: $353,621 · approx sale date: 2026-09-15 · role: Officer · seller: SANDRA CALVIN
2026-09-15 - Planned insider sale (Form 144) - score 87/100
value: $2,603,705 · approx sale date: 2026-09-15 · role: Officer · seller: ELIZABETH REED
2026-09-15 - Planned insider sale (Form 144) - score 87/100
value: $2,939,102 · approx sale date: 2026-09-15 · role: Officer · seller: JULA INRIG
2026-09-15 - Planned insider sale (Form 144) - score 87/100
value: $3,322,921 · approx sale date: 2026-09-15 · role: Officer · seller: CHRISTOPHER CLINE
Being straight about what this is
Not advice. This page reports what two public sources say. It does not tell you what to do with that, and the direction of one does not predict the other.
Some scores are built on incomplete inputs. Where a filing does not publish every term the formula uses, the record carries inputs_complete: false and the score is still shown. The gap is reported, not filled in with a guess.
A short observation window. We started recording opens and closes on this set in August 2026, so "what changed" is weeks deep, not years. It grows daily. The filings themselves reach back as far as the publisher provides.
Refreshed once a night. Not real time, and some publishers are slower by nature: congressional trades weekly, institutional holdings quarterly.
Names come from the filing. Where a person is named, that name is a required disclosure field in the public filing itself, and the link above goes to it.
Everything above for this company in one API call:
curl -H "Authorization: Bearer ds_live_your_key" \
"https://datasignalslab.com/v1/companies/TVTX/events?limit=100"
DataSignals Lab publishes data and research. Informational only, not investment advice, not an offer or solicitation. Every figure links back to the official filing so you can verify it yourself.